Skip to main content
Pellet Therapy 9 min read

EvexiPEL vs BioTE vs SottoPelle — The Complete Pellet System Comparison

Comparing evexipel vs biote vs sottopelle? See how each pellet therapy system differs on dosing, cost, provider training, and patient outcomes.

JR

Jason Revilla

Founder & Lead Researcher, MyHormoneGuide

EvexiPEL vs BioTE vs SottoPelle: The Complete Pellet Therapy Brand Comparison

If you’ve started researching pellet therapy and found yourself drowning in brand names — EvexiPEL vs BioTE vs SottoPelle — you’re not alone. These three systems dominate the pellet BHRT market, and figuring out what actually separates them feels harder than it should be. Most of what you’ll find online is written by providers who are certified in one system and have every reason to say it’s the best. This post isn’t that.

What follows is an honest, side-by-side breakdown of how each system works, where they differ, what patients commonly report, and — most importantly — what those differences actually mean for your care. Because the pellet brand matters far less than most people think, and knowing why will help you ask the right questions when you sit down with a provider.

How Pellet Therapy Works Across All Three Systems

Before comparing brands, it helps to understand that all three systems — BioTE, EvexiPEL, and SottoPelle — deliver bioidentical hormone replacement therapy through the same fundamental mechanism. Small pellets roughly the size of a grain of rice are inserted subcutaneously, typically in the upper buttock, where they dissolve slowly over three to six months, releasing a steady stream of bioidentical estradiol or testosterone directly into the bloodstream.

If you’re brand new to this delivery method, our guide on what hormone pellet therapy is and how it works covers the full picture — including how pellet delivery compares to creams, patches, and injections.

The pellets themselves across all three systems are sourced from FDA-registered 503B compounding pharmacies. They are made of compressed, bioidentical hormone powder — typically plant-derived testosterone or estradiol — and a stearic acid binder. There is no proprietary molecule. The pharmaceutical raw material is largely the same. What these systems have actually built and patented are the clinical protocols, dosing algorithms, provider training programs, and administrative platforms that surround the pellets.

That distinction matters enormously when you’re evaluating these brands. You’re not choosing a different drug. You’re choosing a different methodology for how your dose gets calculated, how your provider gets trained, and how your care gets managed over time.

BioTE: The Largest Network, a Structured Dosing Algorithm

BioTE is the largest pellet therapy franchise in the United States, with a network of over 5,000 certified providers as of recent years. That scale is both its greatest strength and, depending on your situation, a potential limitation worth understanding.

How BioTE calculates dosing: BioTE uses a proprietary, algorithm-based dosing system. Providers input patient lab values — primarily serum testosterone, estradiol, and SHBG — along with patient weight and symptom severity into a portal that generates a recommended pellet dose. This standardization makes training more scalable and helps newer providers avoid dramatic dosing errors. Many patients appreciate the consistency.

The criticism some clinicians raise is that algorithm-driven dosing can underserve patients with unusual physiology — those who metabolize hormones quickly, have high SHBG that affects free hormone levels, or who need doses above what the algorithm typically recommends to achieve full symptom resolution. Whether this affects your care depends heavily on whether your individual provider is willing and able to override the algorithm based on clinical judgment.

The nutraceutical layer: BioTE has built a substantial supplement line — marketed as nutraceuticals — that many BioTE providers recommend alongside pellet therapy. Products like DIM, iodine, and omega-3s are commonly part of the BioTE patient experience. Some patients find this genuinely helpful; others feel it adds cost without proportional benefit. It’s worth asking upfront which supplements your provider considers medically essential vs. optional.

Provider network advantages: With thousands of certified BioTE providers, geographic access is easier for most patients. If you’re using our guide on how to find a pellet therapy provider near you, BioTE’s provider locator is one of the more robust tools available for identifying local options.

EvexiPEL: Optimization-Focused, Smaller and More Selective

EvexiPEL was founded by practitioners who wanted to push beyond what they saw as the limitations of algorithm-only dosing. The system is built around a concept they call “optimization” — the idea that symptom resolution, not just getting labs into a reference range, is the true target of therapy.

How EvexiPEL approaches dosing: EvexiPEL trains providers to use a combination of lab values and symptom assessment rather than relying primarily on an algorithmic output. Providers are encouraged to pursue higher functional testosterone levels in both men and women when symptoms warrant it, rather than defaulting to conservative midrange targets. For patients who feel they were “undertreated” by other systems — labs technically normal, but still exhausted and foggy — this philosophy can be a meaningful difference.

Provider training intensity: EvexiPEL invests heavily in its certification program, which includes both online modules and hands-on clinical training. Because the network is smaller, the barrier to becoming a certified EvexiPEL provider is higher, which can mean more experienced practitioners overall — though this varies by individual.

The tradeoff: Fewer providers means less geographic coverage. Depending on where you live, finding an EvexiPEL provider may require more research or willingness to travel. It also means less peer comparison data — with a smaller network, there’s less published outcome information to draw from.

SottoPelle: The Original Methodology With a Specific Weight-Based Formula

SottoPelle has the longest individual clinical history of the three systems. It was developed by the late Dr. Gino Tutera, an OB/GYN who began using pellet therapy in the 1990s after reviewing data from research going back to the 1930s and 40s. His methodology, which SottoPelle continues to use today, is built on a specific formula that calculates pellet dose primarily based on body weight, blood levels, and symptom category.

How SottoPelle calculates dosing: The SottoPelle formula is more prescriptive than EvexiPEL’s symptom-guided approach and is structured differently from BioTE’s algorithmic portal. It uses a defined calculation that providers apply manually rather than through a software system. Proponents argue this gives providers more direct ownership of the dosing decision. Critics note that the formula was developed from a single physician’s clinical experience rather than randomized controlled trial data — though the same caveat applies to all three systems.

Certification and training: SottoPelle maintains a formal certification process and continuing education requirements for its provider network. Dr. Tutera’s clinical philosophy — that hormones should be dosed to achieve genuine optimization, not just reference-range compliance — is embedded throughout the training.

Patient experience notes: Patients who have tried multiple systems sometimes report that SottoPelle doses feel more consistent insertion to insertion, likely because the manual formula creates high provider accountability for each individual calculation. However, like all systems, individual provider skill remains the dominant variable.

Side-by-Side Comparison: BioTE vs EvexiPEL vs SottoPelle

FeatureBioTEEvexiPELSottoPelle
Founded201220191990s (Dr. Gino Tutera)
Dosing MethodProprietary algorithm/portalSymptom + lab optimizationWeight-based manual formula
Provider Network SizeLargest (~5,000+)Smaller, selectiveMid-size
PhilosophyStandardization at scaleFunctional optimizationPhysician-led precision
Supplement ProgramExtensive nutraceutical lineMinimal brand-specific supplementsMinimal brand-specific supplements
Geographic CoverageWidestLimitedModerate
Training IntensityScalable, portal-basedHigh-intensity, hands-onFormal certification required
Typical Cost Range$300–$900 per insertion$300–$900 per insertion$300–$900 per insertion
Best ForAccess, consistency, new providersPatients previously undertreatedPatients valuing long clinical track record

The honest bottom line: These systems are more similar than different in terms of what they put in your body. The differences that matter most to your outcome — how carefully your symptoms are assessed, how willing your provider is to adjust your dose, how quickly they respond when something feels off — are provider-level differences, not brand-level differences. Two excellent providers using different systems will likely give you similar results. A mediocre provider using any system will frustrate you.

For a clear-eyed look at what the adjustment period actually feels like — and what symptoms are normal vs. worth calling your provider about — read our post on pellet therapy side effects: what’s normal and what’s not.

Frequently Asked Questions

What is the difference between BioTE and EvexiPEL pellet therapy?

BioTE and EvexiPEL are both pellet-based BHRT systems, but they differ in dosing philosophy and provider training. BioTE uses a proprietary algorithm for dosing and has a large national provider network. EvexiPEL emphasizes individualized, optimization-focused dosing with intensive provider education and tends to have a smaller but highly trained provider base. Both use bioidentical hormone pellets compounded to standard specifications. For most patients, the individual provider’s clinical judgment matters more than which system they use.

Is SottoPelle pellet therapy legitimate?

Yes, SottoPelle is a legitimate, physician-founded pellet therapy system with decades of clinical history. Founded by Dr. Gino Tutera, it emphasizes a specific proprietary dosing methodology based on body weight and symptom profile. SottoPelle providers undergo formal training and certification, and the system is used across hundreds of clinics in the United States. Its long track record gives some patients added confidence, though as with any system, provider quality varies.

How do I choose between BioTE, EvexiPEL, and SottoPelle?

Choosing between these systems depends less on the brand and more on the individual provider using it. The most important factors are your provider’s experience, how thoroughly they evaluate your labs, and how willing they are to adjust your dose based on symptoms. Ask any prospective provider which system they use, why, and how they handle dose optimization when a patient doesn’t feel better after the first insertion. Their answers will tell you far more than the brand name will.

Are the hormone pellets themselves different between brands?

The pellets themselves — compressed bioidentical testosterone or estradiol — are largely similar across systems, as all three rely on FDA-registered compounding pharmacies. The primary differences lie in the proprietary dosing formulas, the depth of provider training, the level of ongoing clinical support, and the administrative systems built around the pellets, not the pellets themselves. If you’re comparing brands based on the assumption that the hormones are fundamentally different, that assumption isn’t supported by how these systems actually work.

Which pellet therapy system has the best patient outcomes?

No large-scale head-to-head clinical trial has directly compared BioTE, EvexiPEL, and SottoPelle outcomes. Patient satisfaction data from each system’s own networks tends to be positive but is not independently verified. The broader research on pellet therapy shows benefits for symptom relief in appropriately selected patients, but outcomes depend heavily on correct dosing, provider skill, and individual patient physiology — not the brand name alone.

How much does pellet therapy cost with each system?

Costs vary by provider, location, and dosage, but generally range from $300–$550 per insertion for women and $600–$900 for men across all three systems. BioTE providers may charge additional fees for the proprietary nutraceuticals they often recommend alongside pellets. SottoPelle and EvexiPEL costs are comparable. Most patients need insertions two to four times per year, so annual costs typically range from $1,000–$3,000 depending on frequency and individual dosing needs.

Ready to Explore Pellet BHRT?

Now that you understand how these three systems compare, the most useful next step is finding a provider who takes your symptoms seriously — regardless of which platform they use. Start with our guide to finding a pellet therapy provider near you, which walks you through exactly what to look for, what questions to ask, and how to evaluate a clinic before your first appointment. You can also use the free BHRT Cost Estimator at /tools/cost-estimator/ to build a realistic picture of what pellet therapy will cost in your area before you ever walk through a door. Going in informed isn’t just smart — it’s the difference between getting optimized and getting managed.


The content on this site is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any hormone therapy. Individual results vary.


Common Questions About BioTE, EvexiPEL, and SottoPelle Pellet Therapy

Can I switch from BioTE to EvexiPEL or SottoPelle?

Yes, you can switch pellet systems at any point, typically at the time of your next scheduled insertion. Bring your most recent lab results and insertion records to your new provider so they can calculate your new dose accurately. Most providers who are trained in a different system can work with your history regardless of which brand you started with.

Do I need a new blood test when switching pellet therapy providers?

Most providers will want current lab work before your first insertion with them, even if you have recent results from another clinic. Labs older than three to six months are generally considered outdated for dosing purposes. It’s reasonable to ask whether your new provider will accept recent labs or requires their own panel — this is a practical question worth settling before your appointment.

Is BioTE covered by insurance?

No, BioTE pellet therapy is not typically covered by insurance, and neither are EvexiPEL or SottoPelle. Pellet therapy using compounded hormones falls outside standard insurance coverage in most cases. Some patients use HSA or FSA funds to offset costs. The lab work required for dosing may be partially covered depending on your plan.

How long before I feel results with any of these pellet systems?

Many patients report noticing initial improvements — better sleep, more energy, improved mood — within two to four weeks of their first insertion. Full symptom resolution, including cognitive clarity and libido, often takes one to two full insertion cycles as hormone levels stabilize. The adjustment period is one of the most commonly frustrating parts of early pellet therapy, and it’s normal regardless of which brand system your provider uses.

What happens if my dose is wrong with pellet therapy?

If your pellet dose is too low, your symptoms will persist or partially improve but not resolve fully. If it’s too high, you may experience side effects like acne, hair thinning at the temples, mood irritability, or elevated red blood cell counts. Because pellets can’t be removed once inserted, dose corrections happen at the next insertion cycle. This is why finding an experienced provider who doses conservatively and reassesses carefully is more important than which brand system they use.

References

  1. North American Menopause Society (NAMS). “Hormone Therapy: Benefits & Risks.” Menopause.org, 2022. https://www.menopause.org/for-women/menopauseflashes/menopause-symptoms-and-treatments/hormone-therapy-benefits-risks

  2. Stuenkel, Cynthia A., et al. “Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.” Journal of Clinical Endocrinology & Metabolism, 2015. https://pubmed.ncbi.nlm.nih.gov/26444994/

  3. U.S. Food and Drug Administration. “Bio-identical Hormones: Why the FDA is Concerned.” FDA.gov, 2020. https://www.fda.gov/consumers/consumer-updates/all-about-bioidentical-hormones

  4. Glaser, Rebecca, and Constantine Dimitrakakis. “Testosterone therapy in women: myths and misconceptions.” Maturitas, 2013. https://pubmed.ncbi.nlm.nih.gov/23194825/

  5. Mayo Clinic Staff. “Hormone therapy: Is it right for you?” MayoClinic.org, 2023. https://www.mayoclinic.org/diseases-conditions/menopause/in-depth/hormone-therapy/art-20046372

Medical Disclaimer: The content on this site is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any hormone therapy. Individual results vary.